Stem Pharm Selected for Illumina Accelerator
Stem Pharm, which provides advanced biomaterials for cell and tissue manufacturing, is part of the 10th cycle for the Illumina Accelerator, which began this month in San Francisco. Per the requirements…
Stem Pharm, which provides advanced biomaterials for cell and tissue manufacturing, is part of the 10th cycle for the Illumina Accelerator, which began this month in San Francisco. Per the requirements…
Promega announced today that it will develop its microsatellite instability (MSI) technology for Merck. According to a release, MSI technology may be used to better characterize tumors and guide therapeutic choices for…
Imbed Biosciences announced today that it raised another $2 million in its previously closed Series A funding round, which now totals $4 million. According to release, the round, which closed…
Invenra announced today that it is extending its collaboration with California-based biotech company Exelixis that began in May 2018. According to a release, Exelixis, which focuses on oncology, will continue to use…
Propeller Health announced today that users of its app can use the newly released Find My Inhaler “ring” feature to locate their misplaced inhaler. According to a release, users can…
Phoenix, LLC, unveiled its Phoenix Neutron Imaging Center (PNIC), located in the Uptown neighborhood on the east side of Fitchburg, Wis., last Friday. According to a release, the PNIC is the…
SHINE Medical Technologies announced recently that it closed a $50 million financing round with Oaktree Capital Management. According to a release, the funds will be for the construction of SHINE’s medical…
SHINE Medical Technologies and Phoenix set a world record for a nuclear fusion reaction in a steady-state system, the strongest of its kind ever produced on Earth, SHINE announced today….
Imbed Biosciences, a medical device company that is developing advanced therapies for soft tissue repair, has received a $1.5 million, two-year Small Business Innovation Research (SBIR) grant, the University of…
The U.S. Food and Drug Administration approved Exact Sciences‘ Cologuard for use by eligible average-risk individuals ages 45 and older, the company announced today. Previously, the FDA had approved use…